Editor-in-Chief:

Chandra Prakash
Department of Drug Metabolism and Pharmacokinetics
Biogen Idec
Cambridge, MA
USA

Ken-ichi Fujita (Saitama Medical University, Saitama, Japan)
Lee Jia (Fuzhou University, Fujian, China)


Associate Editor for Europe:

Nico P.E. Vermeulen (Vrije Universiteit Amsterdam, Amsterdam, The Netherlands)


Associate Editors for USA:

Suresh K. Balani (Millennium Pharmaceuticals, Inc., Cambridge, MA, USA)
Ragu Ramanathan (Bristol Myers Squibb, Princeton, NJ, USA)
Michael Sinz (Bristol Myers Squibb, Wallingford, CT, USA)
Zhiyang Zhao (Amgen, Cambridge, MA, USA)
Shufeng Zhou (University of South Florida, Florida, FL, USA)


Editorial Board Members:

K. Bachmann (The University of Toledo, Toledo, OH, USA)
M. Balazy (New York Medical College, Valhalla, NY, USA)
K. Beaumont (Pfizer Global Research and Development, Sandwich Kent, UK)
G.D. Bowers (GlaxoSmithKline, Research Triangle Park, NC, USA)
J. Caldwell (University of Liverpool, Liverpool, UK)
D. Capone (Federico II University, Naples, Italy)
S. Chong (Bristol-Myers Squibb R&D, Pennington, NJ, USA)
R. Dickinson (University of Queensland at Royal Brisbane Hosp., Queensland, Australia)
R. Franklin (Array Biopharma Inc., Boulder, CO, USA)
E.M.J. Gillam (The University of Queensland, St. Lucia, Australia)
H. Glatt (German Institute of Human Nutrition (DIfE), Nuthetal, Germany)
M.J. Gómez-Lechón (La Fe Hospital, Valencia, Spain)
W.G. Humphreys (Bristol-Myers Squibb, Princeton, NJ, USA)
T. Hussain (University of Houston, Houston, TX, USA)
M. Kajbaf (GlaxoSmithKline S.p.A., Fleming, Verona, Italy)
E. Kantharaj (PKDM and Preclinical Development S*BIO Pte Ltd., Singapore Science Park II, Singapore)
T. Károly (Preclinical Imaging Center, Budapest, Hungary)
K. Kassahun (Drug Metabolism Merck & Co., West Point, PA, USA)
T. Kawase (Niigata University, Niigata, Japan)
R.S. King (University of Rhode Island, Kingston, RI, USA)
W.A. Korfmacher (Schering-Plough Research Institute, Kenilworth, NJ, USA)
J. Kirchheiner (University of Ulm, Ulm, Germany)
R.H. Levy (University of Washington, Seattle, WA, USA)
A.P. Li (Advanced Pharmaceutical Sciences Inc., Rockville, MD, USA)
P.I. Mackenzie (Flinders Medical Centre, Bedford Park, Australia)
A.E. Mutlib (Wyeth Research, Collegeville, PA, USA)
A.F. Nassar (Vion Pharmaceuticals Inc., Milford, CT, USA)
J. Neale (Array Biopharma Inc., Boulder, CO, USA)
K.B. Park (University of Liverpool, Liverpool, UK)
A. Rostami-Hodjegan (University of Manchester, Manchester, UK)
M.S. Roberts (University of South Australia, Adelaide, Australia)
T. Rushmore (Merck Research Laboratories, West Point, PA, USA)
J.F. Rusling (University of Connecticut, Storrs, CT, USA)
J. Sahi (CellzDirect Inc., Ann Arbor, MI, USA)
B.L. Tekwani (University of Mississippi, MS, USA)
M. Ulgen (Acibadem University, Istanbul, Turkey)
R.E. White (Schering-Plough Research Institute, Kenilworth, NJ, USA)
B. Wong (Amgen, South San Francisco, CA, USA)
W. Xie (University of Pittsburgh School of Pharmacy, Pittsburgh, PA, USA)
H. Yamazaki (Showa Pharma University, Tokyo, Japan)


Reviewer’s Panel:

J.A.G. Agúndez (University of Extremadura, Badajoz, Spain)
P. Anzenbacher (Palacky University, Olomouc, Czech Republic)
D. Brian (Array Biopharma, Boulder, CO, USA)
E. Chan (National University of Singapore, Singapore, Republic of Singapore)
K.-C. Cheng (Schering-Plough Research Institute, Kenilworth, NJ, USA)
M. Chetty (University of Sydney, Sydney, Australia)
B. Chowbay (National Cancer Centre, 11 Hospital Drive, Singapore, Singapore)
C. Collins (University of Washington, Seattle, WA, USA)
M.T. Donato (Universitat de València, Valencia, Spain)
Z. Dvorak (Palacky University Olomouc, Moravia, Czech Republic)

A. El-Kadi (University of Alberta, Edmonton, Canada)
D. Fuchs (Innsbruck Medical University, Innsbruck, Austria)
A. Galetin (University of Manchester, Manchester, UK)
L.L. Gan (Biogen Idec., Inc., Cambridge, MA, USA)
K. Grime (AstraZeneca Research and Development, Loughborough, UK)
J. Gu (Jilin University, Changchun, China)
J. Hakkola (University of Oulu, Oulu, Finland)
N. Helsby (University of Auckland, Auckland, New Zealand)
N. Hewitt (Scientific Writing Services, Erzhausen, Germany)
P. Honkakoski (University of Eastern Finland, Kuopio, Finland)
M. Hu (University of Houston, Houston, TX, USA)
B. Houston (University of Manchester, Manchester, UK)
F. Innocenti (University of Chicago, Chicago, IL, USA)
H. Jeong (University of Chicago, Chicago, IL, USA)
Y. Jounaidi (Boston University, Boston, MA, USA)
A.S. Kalgutkar (Pfizer Global Research and Development, Groton, CT, USA)
R.A. Kemper (Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USA)
G.M. Kirby (University of Guelph, Guelph, Ontario, Canada)
M. Kranendonk (Universidade Nova de Lisboa, Lisbon, Portugal)
J. Lambert (The Pennsylvania State University, University Park, PA, USA)
M.-C. Liu (University of Toledo, Toledo, OH, USA)
P.H. Marathe (Bristol-Myers Squibb, Princeton, NJ, USA)
F. Martel (University of Porto, Porto, Portugal)
H.H. Maurer (Saarland University, Homburg, Germany)
A. McLachlan (University of Sydney and Concord Hospital, Sydney, Australia)
R.P. Meyer (University of Freiburg, Freiburg, Germany)
B. Moorthy (Baylor College of Medicine, Houston, TX, USA)
A. Nishikawa (National Institute of Health Sciences, Tokyo, Japan)
A. Palotas (Asklepios-Med Bt., Szeged, Hungary)
E. Schuetz (St. Jude Children's Research Hospital, Memphis, TN, USA)
M.-R. Shiran (University of Medical Sciences, Sari, Iran)
W. Tang (Merck Research Laboratories, Rahway, NJ, USA)
R. Tolando (Celsis In Vitro Technologies, Europadamm, Neuss, Germany)
Y.-F. Ueng (Nat. Res. Inst.of Chinese Med., Taipei, Taiwan)
K. Venkatakrishnan (Millennium Pharmaceuticals Inc., Cambridge, MA, USA)
E.L. Woodahl (University of Montana, Missoula, MT, USA)
Z. Yan (Johnson & Johnson Pharmaceutical Research & Development, Spring House, PA, USA)
A. Yu (University at Buffalo, SUNY, Buffalo, NY, USA)
C.-H. Yun (Chonnam National University, Gwangju, Republic of Korea)
J.Y. Zhang (China Novartis Institutes for Biomedical Research Co. Ltd., Shanghai, China)